Please log into your account for a discounted member rate!
Total Credits: 1 including 1 AMA PRA Category 1 Credit(s)™, 1 AOA Category 1-A Credit(s), 1 AOBIM Specialty Credit(s)
This program will expire and must be completed by 07/27/26.
** Please note this program was a part of the VOC 2023. You will not want to choose this program if you completed this individual program as part of the VOC 2023. **
This presentation will discuss options for colon cancer screening, including pros/cons and reliability. Changes in the incidence and demographics of colon cancer will also be addressed, as well as treatment options.
Learning Objectives:
• Learners will describe changes in the incidence of colon cancer.
• Learners will designate appropriate screening methods given a patient's particular circumstances.
• Learners will formulate a comprehensive treatment and monitoring plan for each patient.
• Learners will develop increased rapport to engage the patient in the decision-making process during their treatment.
• Learners will demonstrate improved diagnosis of early-stage colon cancers to improve patient outcomes.
Accreditation Statement:
The Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. MAOPS designates this program for a maximum of 1 AOA Category 1-A CME Credit(s) and will report CME and specialty credits commensurate with the extent of the physician’s participation.
The Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit(s)ä. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Planning Disclosure:
None of the planners for this educational activity have a relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Grievance Policy for AOA Credit:
All grievances should be in writing and should specify the nature of the grievance. Initially, all grievances should be directed to the MAOPS Executive Director, who will then forward said grievance to the Education & Convention Committee. All grievances will receive an initial response in writing within 30 days of receipt. If the participant does not receive a satisfactory response, they can submit a complaint in writing to the Bureau of Osteopathic Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.
| Handout - Sa3B) Dr. Matthew Bechtold - Colon Cancer Screening - Whats New in 2023 (4.63 MB) | 65 Pages | Available after Purchase |
Dr. Matthew Bechtold is a Professor of Clinical Medicine and Clinical Gastroenterologist practicing general gastroenterology and nutrition at the University of Missouri, Columbia. He graduated from the University of Missouri - Columbia School of Medicine. Dr. Bechtold completed his residency and fellowship at the University of Missouri - Columbia & Harry S. Truman Veterans' Hospital in Columbia, Missouri. He is a fellow of the American Gastroenterological Association, the American College of Gastroenterology, the American Society for Gastrointestinal Endoscopy, and the American Society for Parenteral and Enteral Nutrition. Dr. Bechtold is board certified in Gastroenterology and Internal Medicine by the American Board of Internal Medicine.
Despite a busy clinical schedule, Dr. Bechtold has published over 100 articles in outcomes research, nutrition, enteral access, and preventative strategies. He is actively involved in multiple national societies and serves as a member and chair on multiple national committees. He has been a national speaker on gastroenterology, quality improvement, and nutrition topics. He is very passionate about gastrointestinal diseases, nutrition, and quality improvement.
Dr. Bechtold discloses that he has no relevant financial relationships with any organization producing, marketing, reselling, or distributing healthcare goods or services consumed by or used on patients relative to the content of this presentation.
| 5 |
|
| 4 |
|
| 3 |
|
| 2 |
|
| 1 |
|